ESR1 and breast cancer: SRC-3 is a pan-cancer oncogene that functions in a cell-autonomous manner within cancer cells, that is strongly associated with multiple malignancies (38–45) and has been particularly well studied in estrogen receptor positive breast cancer (BC) (38, 46–52).